Press Release: Pharmatech : Pharmatech and Cure Forward to Accelerate Oncology Clinical Trial Enrollment

DENVER & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pharmatech, Inc., with its large network of research-oriented oncology practices, announced today a new collaboration with Cure Forward, a patient activation company. Pharmatech will access Cure Forward's large network of cancer patients to identify clinical study candidates. Through the collaboration, the two companies aim to make clinical trials more accessible in community healthcare settings and support faster approval of targeted therapies for ca